Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection

  • Keith S. Kaye
    Department of Internal Medicine, University of Michigan Medical School, Ann Arbor
  • Tanaya Bhowmick
    Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey
  • Symeon Metallidis
    Department of First Internal Medicine, AHEPA Hospital, Medical School, Aristotle University, Thessaloniki, Greece
  • Susan C. Bleasdale
    Department of Medicine, University of Illinois College of Medicine, Chicago
  • Olexiy S. Sagan
    Department of Urology, Regional Clinical Hospital of Zaporizhizhia, Zaporizhizhia, Ukraine
  • Viktor Stus
    Department of Urology, Dnipropetrovsk Medical Academy of Ministry of Health of Ukraine, Dnipro
  • Jose Vazquez
    Division of Infectious Diseases, Medical College of Georgia, Augusta University, Augusta
  • Valerii Zaitsev
    Clinical Studies Department, Bucovinian State Medical University, Chernivtsi, Ukraine
  • Mohamed Bidair
    San Diego Clinical Trials, San Diego, California
  • Erik Chorvat
    Department of Urology, Urologicke Oddelenie NSP, Poprad, Slovak Republic
  • Petru Octavian Dragoescu
    Department of Urology, Craiova Emergency Clinical Hospital, Craiova, Dolj, Romania
  • Elena Fedosiuk
    Department of Anesthesiology and Intensive Care, Nephrology and Hemocorrection, Brest Regional Hospital, Brest, State Republic of Belarus
  • Juan P. Horcajada
    Hospital del Mar, Infectious Pathology and Antimicrobials Resaearch Group (IPAR)—Institut Hospital del Mar d’Investigaciones Mèdiques (IMIM), Barcelona, Spain
  • Claudia Murta
    Department of Infection Control Service, Santa Casa de Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
  • Yaroslav Sarychev
    Department of Urology with Forensic Medicine, Ukrainian Medical Stomatological Academy, Poltava, Ukraine
  • Ventsislav Stoev
    Department of Urology, Mhat Silistra, Silistra, Bulgaria
  • Elizabeth Morgan
    The Medicines Company, San Diego, California
  • Karen Fusaro
    Melinta Therapeutics, Parsippany, New Jersey
  • David Griffith
    The Medicines Company, San Diego, California
  • Olga Lomovskaya
    The Medicines Company, San Diego, California
  • Elizabeth L. Alexander
    The Medicines Company, Parsippany, New Jersey
  • Jeffery Loutit
    The Medicines Company, San Diego, California
  • Michael N. Dudley
    The Medicines Company, San Diego, California
  • Evangelos J. Giamarellos-Bourboulis
    Fourth Department of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Greece

書誌事項

タイトル別名
  • The TANGO I Randomized Clinical Trial

収録刊行物

  • JAMA

    JAMA 319 (8), 788-, 2018-02-27

    American Medical Association (AMA)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ